Fingerprint
Dive into the research topics of 'Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomized trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomized trial
Claire N Harrison, Adam J Mead, Anesh Panchal, Sonia Fox, Christina Yap, Emmanouela Gbandi, Aimee Houlton, Samah Alimam, Joanne Ewing, Marion Wood, Frederick Chen, Jason Coppell, Nicki Panoskaltsis, Steven Knapper, Sahra Ali, Angela Hamblin, Ruben Scherber, Amylou C Dueck, Nicholas C P Cross, Ruben Mesa
Research output: Contribution to journal › Article › peer-review
66
Citations
(Scopus)